Industry News
Nectin-4 ADCs for Cancer Treatment
At present, only one Nectin-4 ADC drug, Padcev (enfortumab vedotin), has been approved for marketing for the second-line treatment of patients with uroepithelial cancer.
ADCs for HER2-Positive, HER2-Negative &am…
Here, we will analyze the three FDA approved ADCs for the HER2-positive, HER2-low, and HER2-negative breast cancers.
Sales of ADC Drugs From 2020 To 2023
According to the current trend, the total global ADC drug sales are expected to exceed $10 billion in 2023, which will become another important milestone in the ADC field. Below we present th…
Summary of Targeted Protein Degradation i…
Summary of targeted protein degradation, such as PROTAC and molecular glues in clinical trials.
The Role of Helper Lipids in Lipid Nanopa…
What are helper lipids? Whats the role of helper lipids in lipid nanoparticles?
List of New Anti-cancer Drugs Approved By…
So what are the new anti-cancer drugs approved in the first half of the year? As can be seen from the table below, the new drugs approved by the FDA in the first half of the year covered a v…
Combination Therapy of PD-1 Inhibitors An…
If Antibody-drug conjugates (ADC) and PD-1 Inhibitors are used in combination, what kind of sparks will be created?
Bispecific Antibody-drug Conjugate Drugs …
In this article, we will introduce the preclinical data of some currently known bispecific ADC drugs in clinical or preclinical.
Semaglutide: New Therapeutic Potentials
Semaglutide may have the potential to protect against cardiovascular disease, treat NAFLD, fight cancer, alleviate neurodegenerative diseases and reduce addictive behaviors, etc.
List of GLP-1 Receptor Agonists for Diabe…
Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared. …
sales@huatengusa.com
+86 0731 89916275